Statistics
Publications
13
Citations
906
H-Index
12
Active since
2016
Evan Rogers is an author at University of Michigan specializing in medicine, oncology, and tyrosine kinase inhibitors.
Publications per year
2016–2023
13
13
TPX-0046 is a novel and potent RET/SRC inhibitor for RET-driven cancers
Alexander Drilon, Evan Rogers, Dayong Zhai et al. · Annals of Oncology · 2019 · 57 citations
Medicine, Oncology, Pharmacology +12
1–5 of 13